News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Plooster Matthew R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/08/2023 |
4
| Plooster Matthew R (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 49,200 options to buy
@ $0 |
|
| 03/13/2023 |
4
| Plooster Matthew R (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 11,000 shares
@ $4.1953, valued at
$46.1k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 2,500 shares
@ $8.44, valued at
$21.1k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 07/02/2019 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 7,857 shares
@ $0 |
|
| 05/14/2019 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 8,487 shares
@ $0 |
|
| 04/26/2019 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 05/24/2018 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2016 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
|
|